OSLI Retina

January/February 2013

Issue link: http://osliretina.healio.com/i/131354

Contents of this Issue

Navigation

Page 1 of 107

(ocriplasmin) Intravitreal Injection, 2.5 mg/mL ...AVAILABLE FOR YOUR PATIENTS IN JANUARY 2013 J ©2013 ThromboGenics, Inc. All rights reserved. ThromboGenics, Inc., 101 Wood Avenue South, 6th Floor, Iselin, NJ 08830 - USA JETREA and the JETREA logo are trademarks or registered trademarks of ThromboGenics NV in the United States, European Union, Japan, and other countries. THROMBOGENICS and the THROMBOGENICS logo are trademarks or registered trademarks of ThromboGenics NV in the United States, European Union, Japan, and other countries. 11/12 OCRVMA0015 A

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - January/February 2013